Microtubules mobility affects the modulation of L-type I(Ca) by muscarinic and beta-adrenergic agonists in guinea-pig cardiac myocytes.
To investigate the interaction of cytoskeleton with the receptor modulation of ionic currents, we studied the effect of muscarinic and beta-adrenergic stimulation in adult guinea-pig ventricular cardiac myocytes treated with paclitaxel and colchicine, two drugs that respectively stabilize or destabilize microtubules. We observed that the stabilization of microtubules with paclitaxel (1 microM for 1-4 h) did not markedly affect either the kinetics of I(Ca), or the stimulatory effect of isoproterenol (Iso, 1 microM); however paclitaxel significantly blunted the response to carbachol (CCh, 1 microM). In agreement with the electrophysiological measurements, Iso induced a similar enhancement of intracellular cAMP levels in both control and paclitaxel-treated cells, while the response to CCh 1 microM was significantly reduced in paclitaxel-treated cells. The reduction of muscarinic response induced by paclitaxel was also evident in atrial cells, in which the stimulation of I(KACh) by CCh 1 microM was reduced to about 10%. Compared to the muscarinic response, paclitaxel did not have significant effect on the purinergic (adenosine 1-10 microM) modulation of I(Ca). In contrast to paclitaxel, in colchicine-treated cells, I(Ca) was not enhanced by beta-adrenergic stimulation, but instead reduced by CCh, even in the absence of previous stimulation. In conclusion, our data suggest that microtubule stabilization significantly affects the muscarinic modulation of I(Ca), by interacting with the receptor or the G-protein rather than on the intracellular signaling cascade.
Malan
Daniela
D
Dipartimento di Biologia Animale e dell'Uomo, and INFM Unità TO Uni, Università di, Torino, Italy.
Gallo
Maria Pia
MP
Bedendi
Ivano
I
Biasin
Cinzia
C
Levi
Renzo C
RC
Alloatti
Giuseppe
G
D000241:Adenosine / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D016275:Atrial Function; D020746:Calcium Channels, L-Type / Q000378:metabolism*; D002217:Carbachol / Q000494:pharmacology; D002478:Cells, Cultured; D003078:Colchicine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004553:Electric Conductivity; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D007124:Immunoenzyme Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008870:Microtubules / Q000187:drug effects / Q000502:physiology*; D009068:Movement; D018721:Muscarinic Agonists / Q000494:pharmacology*; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D017239:Paclitaxel / Q000494:pharmacology; D058913:Purinergic Agonists
D000318:Adrenergic beta-Agonists; D020746:Calcium Channels, L-Type; D018721:Muscarinic Agonists; D058913:Purinergic Agonists; D002217:Carbachol; D000242:Cyclic AMP; D000241:Adenosine; D007545:Isoproterenol; D017239:Paclitaxel; D003078:Colchicine